A Phase 1 interventional study of Rotavirus (Bio Farma) Vaccine and Placebo in Safety Issues, sponsored by PT Bio Farma. Completed at 4 sites in Indonesia. Open to participants aged 1 Minute to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-04-03.
Sponsored by PT Bio Farma · Phase 1, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study is to assess the safety of Rotavirus (Bio Farma) vaccine in adults, children and neonates.
To describe the safety of this vaccine after each immunization. To assess preliminary information of immunogenicity following Rotavirus (Bio Farma) vaccine immunization.
PT Bio Farma is the lead sponsor of 47 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria for Adults:
Inclusion Criteria for Children:
Inclusion Criteria for Neonates:
Exclusion Criteria for Adults:
Exclusion Criteria for Children:
Exclusion Criteria for Neonates:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
1 doses of 1 ml of Rotavirus vaccine per oral
Biological: Rotavirus (Bio Farma) Vaccine
1 doses of 1 ml of Rotavirus vaccine per oral
Biological: Rotavirus (Bio Farma) Vaccine
3 doses of 1 ml of Rotavirus vaccine per oral
Biological: Rotavirus (Bio Farma) Vaccine
3 doses of 1 ml of Placebo (contains 30% sucrose in DMEM) per oral
Other: Placebo
Rotavirus (Bio Farma) Vaccine
Placebo contains 30% sucrose in DMEM
Solicited symptoms after each immunization
Number of subjects with solicited systemic and gastrointestinal symptoms in the day 0-7 following each dose of investigational product
Time frame: 0-7 days
Adverse events of Rotavirus (Bio Farma) vaccine
Number and percentage of subjects with unsolicited Adverse Events (AE) in the day 0-28 following each dose of investigational product
Time frame: 28 days
Serious adverse events of Rotavirus (Bio Farma) vaccine
Number and percentage of subjects with Serious Adverse Events (SAE) within 28 days after each dose of investigational product
Time frame: 28 days
Adverse events of Rotavirus (Bio Farma) vaccine compare to placebo in neonates group
Number and percentage of subject with adverse event (AE) within 28 days after each dose of investigational product compare to placebo (in neonates group)
Time frame: 28 days
Serious adverse events of Rotavirus (Bio Farma) vaccine compare to placebo in neonates group
Number and percentage of subject with Serious Adverse Events (SAE) within 28 days after each dose of investigational product compare to placebo (in neonates group)
Time frame: 28 days
Number of subject who has abnormality value of routine hematology and biochemical evaluation that probably related to the vaccination
Deviation in routine hematology and biochemical evaluation
Time frame: 7 days
Excretion of rotavirus in stools in neonates group
Number of neonates with rotavirus excretion in stools
Time frame: 3-7 days
Number of subjects with >=3 times increasing antibody from baseline to post investigational product dosing
Subjects with \>=3 times increasing antibody from baseline to post investigational product dosing
Time frame: 4-6 weeks after last immunization
Serum anti-rotavirus immunoglobulin (Ig)A following immunization
Serum anti-rotavirus immunoglobulin (Ig)A before and after last immunization
Time frame: 4-6 weeks after last immunization
Serum neutralizing antibody (SNA) following immunization
Serum neutralizing antibody (SNA) before and after last immunization
Time frame: 4-6 weeks after last immunization
Geometric Mean Titer (GMT) following immunization
Geometric mean titer (GMT) before and after last immunization
Time frame: 4-6 weeks after last immunization
Plan to share: No
No publications or documents are linked to this record.
Ran from Apr 2018 to primary completion in Feb 2019, 10 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.